Axxess Pharma, Inc. AXXE Company Overview  Stock Message

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Axxess Pharma, Inc. AXXE Company Overview 

Stock Message Board http://investorshangout.com/search?q=AXXE&...mp;yt1=Go!

Axxess Pharma, Inc. AXXE Current Price and Quotes
0.90
Previous Close
0.88
Open
0.89

Daily Range
0.90 - 0.89
52wk Range
1.03 - 0.74

Volume
1,000
Dividend
N/A

Average Vol (3m)
5,144
Yield
N/A

Axxess Pharma, Inc. AXXE
Company Information
2681 Eglinton Ave West
Toronto, ONT M6M-1T8
Canada

Website: http://www.axxesspharmainc.com
Phone: (888) 631-3947
Email: danielb@axxesspharmainc.com

Axxess Pharma, Inc. AXXE
Axxess Pharma, Inc. is a pharmaceutical company specializing in the marketing and distribution of both prescription and non-prescription medical products in niche markets. Although they serve the General Practice market, Axxess Pharma, Inc. also distributes products that target Dermatology, Rheumatology, Gynecology, Urology and Nephrology markets.

Axxess Pharma, Inc. AXXE
Financial Reportings and Disclosures
Reporting Status Alternative Reporting Standard
Audited Financials Unaudited
Latest Report Jun 30, 2013 Quarterly Report
CIK 0001103309
Fiscal Year End 12/31
OTC Marketplace OTC Pink Current
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Aug 15, 2012
Incorporated In: DE, USA
Year of Inc. 1997
Employees 17 a/o Jul 24, 2008
Company Officers/Contacts
Daniel Bagi President, CEO
Company Directors
Not Available
Company Notes
Formerly=CGI Communications Services, Inc. until 7-2008
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Anslow & Jaclin, LLP
195 Route 9 South
Manalapan, NJ, 07726
United States

Investor Relations Firm
Taylor Capital, Inc.
104 N Munn Ave
Newark, 07106
United States


Axxess Pharma, Inc. AXXE
AXXE Security Details
Share Structure
Market Value1 $35,153,877 a/o Aug 30, 2013
Shares Outstanding 39,059,863 a/o Mar 31, 2013
Float Not Available
Authorized Shares Not Available
Par Value  Not Available
Shareholders
Shareholders of Record Not Available
Security Notes
Capital Change=shs decreased by 1 for 5 split Pay date=07/30/2008.
Capital Change=shs decreased by 1 for 750 split. Ex-date=04/12/2012.
Short Selling Data
Short Interest 795 (79,400%)
Aug 15, 2013
Significant Failures to Deliver  No
Transfer Agent(s)
Corporate Stock Transfer, Inc.

Axxess Pharma, Inc. AXXE Recent News


Aug 15, 2013 Axxess Pharma Inc. Announces Two-Time Canadian Heavyweight Boxing Champion Ray Olubowale as Spokesperson and Corporate Ambassador
Aug 1, 2013 AXXESS Pharma, Inc. Announces License Agreement with Canadian Manufacturer of Cancer Drugs
Jul 24, 2013 Axxess Pharma, Inc. Announces MOU for Exclusive World-Wide License Rights for TapouT Brand Vitamins and Pain Relief Products
Jul 17, 2013 Dr. Daniel Bagi, President and CEO of Axxess Pharma, Inc., is Featured in a New Audio Interview at SmallCapVoice.com
Jul 16, 2013 Axxess Pharma Inc. in Discussions for World-Wide Rights with Leading Sporting Brand
Jul 10, 2013 Axxess Pharma, Inc. Announces Key Addition to Management with Appointment of Senior Vice President of Sales & Marketing
Jun 4, 2013 Axxess Pharma Inc. Receives Upgraded Listing on OTCMarkets.com


Axxess Pharma, Inc. AXXE Financials
AXXE

AXXE Axxess Pharma, Inc. Research DD Guide

AXXE Axxess Pharma, Inc. Stock Message Board http://investorshangout.com/search?q=AXXE&...mp;yt0=Go!
AXXE Axxess Pharma, Inc. Stock Quote http://www.otcmarkets.com/stock/AXXE/quote
AXXE Axxess Pharma, Inc. Stock Chart http://www.otcmarkets.com/stock/AXXE/chart
AXXE Axxess Pharma, Inc. Company Info http://www.otcmarkets.com/stock/AXXE/company-info
AXXE Axxess Pharma, Inc. Recent News http://www.otcmarkets.com/stock/AXXE/news
AXXE Axxess Pharma, Inc. Financials http://www.otcmarkets.com/stock/AXXE/financials
AXXE Axxess Pharma, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/AXXE/filings
AXXE Axxess Pharma, Inc. Short Sales http://www.otcmarkets.com/stock/AXXE/short-sales
AXXE Axxess Pharma, Inc. Insider Disclosure http://www.otcmarkets.com/stock/AXXE/insider-transactions
AXXE Axxess Pharma, Inc. Research Reports http://www.otcmarkets.com/stock/AXXE/research
AXXE Axxess Pharma, Inc. Summary http://finance.yahoo.com/q?s=AXXE
AXXE Axxess Pharma, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=AXXE+Historical+Prices
AXXE Axxess Pharma, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=AXXE
AXXE Axxess Pharma, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=AXXE+Basic+Chart
AXXE Axxess Pharma, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=AXXE+Basic+Tech.+Analysis
AXXE Axxess Pharma, Inc. Headlines http://finance.yahoo.com/q/h?s=AXXE+Headlines
AXXE Axxess Pharma, Inc. Press Releases http://finance.yahoo.com/q/p?s=AXXE+Press+Releases
AXXE Axxess Pharma, Inc. Company Profile http://finance.yahoo.com/q/pr?s=AXXE+Profile
AXXE Axxess Pharma, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=AXXE+Key+Statistics
AXXE Axxess Pharma, Inc. Industry http://finance.yahoo.com/q/in?s=AXXE+Industry
AXXE Axxess Pharma, Inc. Major Holders http://finance.yahoo.com/q/mh?s=AXXE+Major+Holders
AXXE Axxess Pharma, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=AXXE+Insider+Transactions
AXXE Axxess Pharma, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=AXXE+Insider+Roster
AXXE Axxess Pharma, Inc. Income Statement http://finance.yahoo.com/q/is?s=AXXE
AXXE Axxess Pharma, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=AXXE
AXXE Axxess Pharma, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=AXXE+Cash+Flow&annual
AXXE Axxess Pharma, Inc. Nasdaq http://www.nasdaq.com/symbol/AXXE
AXXE Axxess Pharma, Inc. Market Watch http://www.marketwatch.com/investing/stock/AXXE
AXXE Axxess Pharma, Inc. Bloomberg http://www.bloomberg.com/quote/AXXE:US
AXXE Axxess Pharma, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=AXXE
AXXE Axxess Pharma, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=AXXE
AXXE Axxess Pharma, Inc. Barchart http://www.barchart.com/quotes/stocks/AXXE
AXXE Axxess Pharma, Inc. OTC Short Report http://otcshortreport.com/index.php?index=AXXE
AXXE Axxess Pharma, Inc. Investopedia http://www.investopedia.com/markets/stocks/AXXE/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Montessori and Tech: A New Era of Integration

Updated Category News Views 13

Reimagining Montessori with Technology Let's take a stroll down the road less traveled—the intersection of Montessori education and tech. For over a century, Montessori schools have valued individual child development, autonomy, and a purpose-driven environment. But let's face it, their technology hasn't always had the same handcrafted finesse. That's where illumine...

Continue Reading
Omneky Outshines Competitors in AI Ad Scoring

Updated Category News Views 15

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Continue Reading
Fluence Energy Faces Major Lawsuit Amid $3B Loss

Updated Category News Views 7

Securities Class Action: A Storm Brewing Just when you think you've got a grip on the market, a sharp right hook can come out of nowhere. Fluence Energy (NASDAQ:FLNC) is dealing with one of those punches now, getting dragged into the courtroom over claims they fudged financial lines. They hail innovation in energy storage, but shareholders are left shaking in their boots...

Continue Reading
TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Updated Category News Views 12

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Continue Reading
Coventry's Jacobs Joins European Life Settlement Execs

Updated Category News Views 15

Neal Jacobs Steps Up in Life Settlements Coventry has added another feather to its cap with Neal Jacobs, their Senior Managing Director of Capital Markets, joining the Executive Committee of the European Life Settlement Association (ELSA). Elected at ELSA's Annual General Meeting on September 15, 2026, Jacobs brings a wealth of experience that promises to bolster the...

Continue Reading
VetsinTech's AI Training Boosts Military Careers

Updated Category News Views 22

A New Spin on Engineering Careers Sometimes it feels like every corner I turn in this market maze, there’s something about AI. It’s not just chirping in the tech world anymore; it’s banging on the doors of sectors like engineering, aerospace, and manufacturing. And now, VetsinTech is tossing its hat into the AI ring with a fresh program aimed at blending military...

Continue Reading
OmniActive's Fenavari: A New Era in Women's Health

Updated Category News Views 17

Pioneering Women's Health with Fenavari You ever wonder why some health products get all the hype? Here's one for the book: OmniActive Health Technologies launching Fenavari, their top-tier contender in the women's health market. Now, we're not talking your run-of-the-mill supplement here. We're stepping onto a new playing field, especially with Dr. Taz Bhatia stepping...

Continue Reading
Skiptown Expands in Georgia Amid Growing Demand

Updated Category News Views 10

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Continue Reading
Think Tank Pushes for Bold Parkinson's Prevention Plan

Updated Category News Views 14

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Continue Reading
AtWork Welcomes Franchise Vet Sarah Goehring

Updated Category News Views 12

A Strategic Move for AtWork There's a new heavyweight at AtWork, a name that's been catching attention in the franchise biz lately—Sarah Goehring. This isn't just another appointment; it's a signal flare for AtWork's ambitions. With Goehring, they're doubling down on scaling their operation and drawing in more franchise players who are ready to hit the ground running....

Continue Reading

Top 5 Most Recently Viewed Articles

Rohirrim Introduces RohanProcure for Advanced Gov Procurement

Updated Category News Views 604

Rohirrim Unveils RohanProcure to Transform Government Procurement Rohirrim, an innovative leader in AI technologies, has recently launched RohanProcure, a specialized platform aimed at modernizing government procurement processes. This cutting-edge, single-tenant, defense-grade GenAI solution is designed to streamline acquisition workflows, significantly reducing clerical...

Continue Reading
Elite Supplements Partners with Coveo for Enhanced Ecommerce Growth

Updated Category News Views 76

Elite Supplements and Coveo: A Strategic Collaboration In a bold move towards enhancing customer experience, Australian sports-nutrition innovator Elite Supplements has teamed up with Coveo and Shopify. This strategic partnership aims to elevate product discovery, personalization, and conversion across their extensive 130-store omnichannel brand. Elite Supplements, one of...

Continue Reading
ALK's ITULAZAX® Approval Marks Progress in Allergy Treatment

Updated Category News Views 188

ALK's Innovative ITULAZAX® Tablet Gains NICE Recommendation ALK (ALKB:DC / OMX: ALK B) is thrilled to announce a significant advancement in allergy treatment with the National Institute for Health and Care Excellence (NICE) recommending the company’s tree pollen tablet, ITULAZAX®, for adult patients. This critical endorsement enables easier access through the National...

Continue Reading
AMG Critical Materials Sells Graphit Kropfmühl to Asbury Carbons

Updated Category News Views 315

AMG Critical Materials Finalizes Sale of Graphit Kropfmühl GmbH AMG Critical Materials N.V. (EURONEXT AMSTERDAM: AMG) recently confirmed a significant business move with its decision to sell Graphit Kropfmühl GmbH (GK) to Asbury Carbons Inc. This strategic transaction aligns with AMG's intention to prioritize its core operations and harness new growth opportunities....

Continue Reading
Impact Climate Technologies Expands with New Acquisition

Updated Category News Views 131

Impact Climate Technologies Strengthens Its Portfolio Impact Climate Technologies (ICT), a prominent player in the HVAC industry, has announced its latest strategic move to enhance its capabilities by acquiring Larry Wunsch & Associates, Inc. This acquisition is set to bolster ICT's operational footprint while expanding its service offerings in the HVAC and plumbing...

Continue Reading